ARWR - Arrowhead Pharmaceuticals, Inc.

Name: Arrowhead Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Insider activity in ARWR over the last quarter tilts toward selling: insiders offloaded a net 13,600 shares worth roughly $1.2M.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Christopher Richard Anzalone	3.79M	$225.78M	-
COO	Patrick O'Brien	547.4K	$32.59M	-
Other	James C Hamilton	227.0K	$13.51M	-
CFO	Daniel Joseph Apel	162.9K	$9.70M	-
Dir	Michael S Perry	111.5K	$6.64M	-

Activity

Buys and sells only

Transactions

10 filings · page 13

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Apr 14, 2020	Douglas B Given66	Director	Sell	25,000	$36.89	$922,250.00	-13.8%
Jan 21, 2020	Kenneth Allen Myszkowski68	Chief Financial Officer	Sale+OE	40,313	$49.44	$1,992,924.63	-9.5%
Jan 6, 2020	Patrick O'Brien76	General Counsel	Sell	14,625	$60.12	$879,260.67	-5.4%
Jan 6, 2020	Kenneth Allen Myszkowski68	Chief Financial Officer	Sell	20,000	$60.11	$1,202,200.60	-4.9%
Jan 6, 2020	Bruce D Given	Chief Operating Officer	Sell	35,613	$60.13	$2,141,285.21	-4.0%
Dec 24, 2019	Christopher Richard Anzalone60	Chief Executive Officer	Sell	83,333	$63.50	$5,291,645.50	-4.4%
Dec 13, 2019	Christopher Richard Anzalone60	Chief Executive Officer	Sell	183,333	$67.15	$12,310,119.07	-8.8%
Dec 3, 2019	Christopher Richard Anzalone60	Chief Executive Officer	Sell	50,000	$67.33	$3,366,521.82	-2.4%
Nov 1, 2019	Kenneth Allen Myszkowski68	Chief Financial Officer	Sale+OE	37,884	$40.85	$1,547,378.04	-10.8%
Oct 10, 2019	Christopher Richard Anzalone60	Chief Executive Officer	Sale+OE	56,325	$31.83	$1,792,824.75	-2.6%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC